S&P 500NasdaqDow JonesS&P 500NasdaqDow JonesS&P 500NasdaqDow JonesS&P 500NasdaqDow Jones

Loading report…

RESEARCH REPORT

T-REX 2X Long SPCX Daily Target

SPAX

$10.57

As of 2026-09-19

Research note — 2026-09-19. Educational analysis, not financial advice.


The one-line version

A leveraged daily ETF trading at 17.7× trailing earnings sits at the intersection of sustained bull-market momentum and the structural decay inherent in 2× daily reset products. That's the tension. Everything below is the detail.

That's the tension. Everything below is the detail.


1. What you're paying

What you're paying

MetricValueNotes
Trailing P/E17.7×Based on $0.60 trailing EPS
Forward P/ENot available
Historical median P/EUnavailable from clean history
Gap to medianCannot calculate
Trailing EPS$0.60
Gross marginNot disclosed

At $10.57 per share, you're paying 17.7× trailing twelve-month earnings of $0.60 per share. Without historical P/E data for comparison, there's no clear baseline to judge whether this multiple represents a premium or discount to the fund's typical valuation range. As a leveraged daily-reset product, traditional P/E analysis may not capture the structural mechanics at work.

No analyst targets or fair-value models are available for this instrument.

2. What the bulls are counting on

Daily momentum capture in a rising market — The 2× daily leverage amplifies same-day gains in the underlying SPCX index; if markets trend upward with minimal intraday volatility, the fund delivers approximately double the daily return, compounding favorably over short periods.

Trailing profitability of $0.60 EPS demonstrates recent functionality — The fund has generated measurable earnings over the trailing period, suggesting that fee structures and operational costs have not overwhelmed the leveraged return mechanism during this window.

Structural demand from tactical traders — Leveraged ETFs attract repetitive volume from day traders and momentum players seeking amplified exposure without margin accounts, creating persistent liquidity and potential price support from technical buyers.

No apparent operational red flags — The fund is priced, trading, and reporting earnings without disclosure of structural issues, lawsuits, or NAV dislocations that often plague distressed leveraged products.

Sign up free to read the full analysis

Bull case, bear case, assumptions, and what to watch next.

3. What the bears see

Daily reset decay erodes value in choppy markets — The 2× leverage resets each day; in volatile sideways markets, the compounding math works against holders as losses are magnified on down days and gains fail to recover the principal, causing structural value erosion independent of the underlying index direction.

Leveraged products are not designed for multi-day neutral notes — The fund's construction targets daily performance; holding beyond a single session exposes market participants to path-dependent returns where the sequence of gains and losses materially impacts outcomes, often underperforming 2× the cumulative index move over weeks or months.

Unknown underlying exposure and concentration risk — With no sector classification or holdings detail in the snapshot, the composition of SPCX remains opaque; concentration in a narrow theme or volatile subsector could amplify drawdowns beyond what 2× leverage alone suggests.

P/E ratio may misrepresent economic reality — The trailing EPS of $0.60 reflects recent market conditions and fee structures; a shift in volatility regime, rebalancing costs, or derivative pricing could turn profits to losses rapidly, rendering the 17.7× multiple meaningless.

Lack of forward guidance or earnings visibility — With no forward P/E, analyst coverage, or next earnings date, there's zero visibility into sustainability of the $0.60 EPS run rate or management's outlook on cost structures.

Recession or sustained drawdown would compound losses — A 10% decline in the underlying index on a given day would result in an approximate 20% loss in SPAX; a multi-week bear market would see losses pile on top of each other through daily resets, potentially causing catastrophic NAV erosion.

Sign up free to read the full analysis

Bull case, bear case, assumptions, and what to watch next.

4. What would have to be true

For the stock to justify a 17.7× trailing P/E — absent any historical median for context — roughly all of the following need to neutral:

  1. The underlying SPCX index continues a steady upward trend with low intraday volatility, allowing daily compounding to work in favor of the 2× leverage rather than eroding principal through whipsaw.
  1. The recent trailing twelve months represent a sustainable earnings environment, meaning fee drag, rebalancing costs, and derivative expenses remain at or below the levels that produced $0.60 EPS.
  1. market participants continue to value tactical leverage products at equity-like multiples, rather than discounting them for structural decay, finite neutral periods, or the lack of fundamental earnings growth.
  1. No regime shift occurs in market volatility or correlation structures that would materially increase the cost of maintaining 2× daily exposure or trigger sustained sideways price action.
  1. The fund maintains operational integrity and liquidity without NAV dislocations, tracking errors, or structural failures common in leveraged products during stress.
  1. Holders remain predominantly short-term traders who exit before compounding decay materializes, preventing a collapse in demand from bullish-and-neutral market participants discovering underperformance.

How many of these six would you bet on individually holding true over the next 6–12 months? What happens to a 17.7× multiple if one or two break?

Sign up free to read the full analysis

Bull case, bear case, assumptions, and what to watch next.

5. What to watch next

  • Daily tracking error vs. 2× SPCX performance — calculate whether SPAX is delivering the stated leverage or if slippage and decay are widening; sustained deviation signals operational stress or hidden costs.
  • Volatility regime of the underlying index — monitor whether SPCX enters a choppy, range-bound period; rising intraday swings without directional trend will accelerate compounding decay.
  • Next earnings release or fund disclosure — watch for any updated EPS, expense ratio changes, or management commentary on rebalancing costs and derivative market conditions.
  • Volume and liquidity trends — falling average daily volume or widening bid-ask spreads can indicate waning interest in the product and increase execution risk for holders.
  • NAV vs. market price divergence — if the fund's net asset value per share begins to drift materially from the trading price, it signals structural stress or forced liquidation risk.
  • Underlying SPCX composition or reconstitution announcements — any shift in what the base index neutral notes changes the risk profile and sector exposures that the 2× leverage amplifies.

Sign up free to read the full analysis

Bull case, bear case, assumptions, and what to watch next.


6. What this note does not do

It doesn't tell you to buy or sell. It won't, ever.

You have the valuation in context, the strongest version of both cases, and the specific assumptions the current price depends on. What you do with that depends on your time horizon, your existing exposure, your risk tolerance, and what else you could do with the money — none of which we know.

If you want someone to tell you what to do, you want a licensed financial adviser, and that is a genuinely reasonable thing to want.

Educational and informational purposes only. Not investment advice and not a recommendation to buy or sell any security. GetStockReport is not a registered investment adviser. Figures are as of 2026-09-19 and go stale quickly — verify against primary sources before acting. All investments carry risk including loss of principal. Past performance does not guarantee future results.


8. Analyst ratings & targets

No recent activity

Analyst opinions change frequently. Past upgrades do not predict future returns.


9. Important news

No recent activity

News headlines are reported as-is. Verify important claims with original sources.


10. Insider Form 4 activity

No recent activity

Form 4 filings are routine transactions. Scheduled sales (10b5-1 plans) are normal and not signals.


11. Institutional 13F holdings

No recent activity

These are 45-day lagged filings (SEC requirement). Position changes happened in the past.


12. Earnings this week

No recent activity

Earnings dates are estimates and may shift. EPS estimates are consensus, not predictions.

← Browse all reports